Contrast 3 |
Upregulated DE genes
|
|
|
|
GO:0006412 translation |
3.31E–05 |
31/186 (16.7%) |
787/14,580 (5.4%) |
GO:0044237 cellular metabolic process |
1.87E–04 |
96/186 (51.6%) |
4,811/14,580 (33.0%) |
GO:0009161 ribonucleoside monophosphate metabolic process |
2.16E–04 |
12/186 (6.5%) |
132/14,580 (0.9%) |
GO:0009123 nucleoside monophosphate metabolic process |
2.35E–04 |
12/186 (6.5%) |
133/1,580 (0.9%) |
GO:0046034 ATP metabolic process |
3.67E–04 |
11/186 (5.9%) |
113/14,580 (0.8%) |
GO:0032543 mitochondrial translation |
6.05E–04 |
6/186 (3.2%) |
23/14,580 (0.2%) |
GO:0009167 purine ribonucleoside monophosphate metabolic process |
1.11E–03 |
11/186 (5.9%) |
126/14,580 (0.9%) |
GO:0009126 purine nucleoside monophosphate metabolic process |
1.11E–03 |
11/186 (5.9%) |
126/14,580 (0.9%) |
GO:0010467 gene expression |
4.08E–03 |
56/186 (30.1%) |
2,397/14,580 (16.4%) |
GO:0044249 cellular biosynthetic process |
5.38E–03 |
56/186 (30.1%) |
2,418/14,580 (16.6%) |
Downregulated DE genes
|
|
|
|
None |
|
|
|
Commonality between Contrasts 2, 4, and 5 |
Upregulated DE genes
|
|
|
|
GO:0050896 response to stimulus |
1.11E–10 |
104/263 (39.5%) |
2,855/14,580 (19.6%) |
GO:0006950 response to stress |
3.34E–10 |
57/263 (21.7%) |
1,084/14,580 (7.4%) |
GO:0002376 immune system process |
1.04E–09 |
33/263 (12.5%) |
405/14,580 (2.8%) |
GO:0006952 defense response |
9.74E–08 |
29/263 (11.0%) |
373/14,580 (2.6%) |
GO:0044699 single-organism process |
6.35E–07 |
194/263 (73.8%) |
8,031/14,580 (55.1%) |
GO:0006955 immune response |
2.61E–06 |
24/263 (9.1%) |
298/14,580 (2.0%) |
GO:0065007 biological regulation |
5.27E–06 |
109/263 (41.4%) |
3,621/14,580 (24.8%) |
GO:0044763 single-organism cellular process |
7.96E–06 |
154/263 (58.6%) |
5,930/14,580 (40.7%) |
GO:0045087 innate immune response |
6.92E–05 |
16/263 (6.1%) |
157/14,580 (1.1%) |
GO:0044707 single-multicellular organism process |
2.72E–04 |
115/263 (43.7%) |
4,170/14,580 (28.6%) |
Downregulated DE genes
|
|
|
|
GO:0042335 cuticle development |
3.78E-12 |
27/242 (11.2%) |
234/14,580 (1.6%) |
GO:0040003 chitin-based cuticle development |
7.15E–11 |
23/242 (9.5%) |
182/14,580 (1.2%) |
GO:0030239 myofibril assembly |
8.95E–10 |
12/242 (5.0%) |
37/14,580 (0.3%) |
GO:0055002 striated muscle cell development |
6.24E–08 |
12/242 (5.0%) |
51/14,580 (0.3%) |
GO:0055001 muscle cell development |
6.24E–08 |
12/242 (5.0%) |
51/14,580 (0.3%) |
GO:0031032 actomyosin structure organization |
2.26E–07 |
13/242 (5.4%) |
70/14,580 (0.5%) |
GO:0006030 chitin metabolic process |
3.65E–07 |
16/242 (6.6%) |
122/14,580 (0.8%) |
GO:1901071 glucosamine-containing compound metabolic process |
1.07E–06 |
16/242 (6.6%) |
131/145,80 (0.9%) |
GO:0006040 amino sugar metabolic process |
1.21E–06 |
16/242 (6.6%) |
132/14,580 (0.9%) |
GO:0006022 aminoglycan metabolic process |
5.98E–06 |
16/242 (6.6%) |
147/14,580 (1.0%) |